Skip to main content

Find Clinical Trials

Home
Conditions
Liver Neoplasms

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 462 recruiting studies

Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Recruiting

Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab

NCT06796114

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU de Besançon Besançon, France

CH de Chalon sur Saône Chalon-sur-Saône, France

CHU Grenoble Grenoble, France

CH de Mulhouse Mulhouse, France

View Trial Details

Recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT05208762

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

View all 62 locations

View Trial Details

Recruiting

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

NCT07219459

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

Peidmont Healthcare, Inc Atlanta, Georgia, United States

OSF St. Francis Medical Center Peoria, Illinois, United States

Hannover Medical School Hanover, Lower Saxony, Germany

View all 14 locations

View Trial Details

Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

NCT07419841

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Nebraska Cancer Specialists Omaha, Nebraska, United States

START New York Lake Success, New York, United States

UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

NCT07284121

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: Landesklinikum Krems Krems, Austria

Ordensklinikum Linz Elisabethinen Linz, Austria

Krankenhaus Nord - Klinik Floridsdorf Vienna, Austria

Klinikum Wels-Grieskirchen Wels, Austria

View all 91 locations

View Trial Details

Recruiting

Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)

NCT06796803

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

Zhongshan Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

NCT06990659

Conditions: Adenocarcinoma, Behavior, Carcinoma, +15 more
Locations: University hospital of Amiens Amiens, France

University hospital of Angers Angers, France

University hospital of Besançon Besançon, France

Hospital of Avicennes (AP-HP) Bobigny, France

View all 19 locations

View Trial Details

Recruiting

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

NCT05092373

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Breast Carcinoma, +110 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

San Raffaele Registry on Liver Cancer

NCT07704489

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Recruiting

To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization

NCT06478719

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: National Taiwan University Hospital Taipei, Taiwan

Linkou Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details